Additional Shares

 
News Articles for Additional Shares top ^
2014/8/29
SYNCHRONY FINANCIAL (“Synchrony”) announced that the underwriters for its initial public offering of common stock have partially exercised their option to purchase additional shares and purchased an additional 3,493,756 shares.
Sign-up for Synchrony Financial Announces Exercise of Underwriters’ Option to Purchase 3,493,756 Additional Shares investment picks
NATICK, Mass., June 30, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI) today announced that the underwriters of its previously announced public offering of common stock have exercised their option to purchase an additional 397,087 shares of its common stock at a price of $42.50 per share before underwriting discounts.
Sign-up for Karyopharm Announces Full Exercise of Underwriters Option to Purchase Additional Shares in Public Offering of Common Stock investment picks
NOVATO, Calif., July 14, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (Nasdaq:RARE) , a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced the closing of its public offering of 2,319,951 shares of common stock at a price to the public of $40.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to 302,602 additional shares of common stock.
Sign-up for Ultragenyx Announces Closing of Public Offering of Common Stock and Exercise of Underwriters' Option to Purchase Additional Shares investment picks
Signature Bank (Nasdaq: SBNY), a New York-based full service commercial bank, announced today that J.P. Morgan, the investment bank that acted as sole bookrunner in its recent public stock offering, which closed on June 13, 2014, exercised in full the option the Bank had granted the firm to purchase up to 315,000 additional shares of common stock.
Sign-up for Signature Bank Announces Underwriter’s Purchase of Additional Shares in Recent Public Stock Offering investment picks
2014/8/19
Harry Steele acquires additional shares of Newfoundland Capital Corporation Limited Canada NewsWire DARTMOUTH, NS , Aug.
Sign-up for Harry Steele acquires additional shares of Newfoundland Capital Corporation Limited investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1140151&ProfileId=051205&sourceType=1 NICOSIA, CYPRUS --
Sign-up for Trafigura Acquires Additional Shares in EMED investment picks
WEST CHESTER, Ohio , Sept.
Sign-up for AK Steel Announces Full Exercise of Underwriters' Option to Purchase Additional Shares of Common Stock investment picks
Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products today reaffirms its guidance issued on its earnings call on September 4, 2014 in conjunction with the announcement of the underwriters’ exercise of its option to purchase additional shares in connection with the Initial Public Offering.
Sign-up for Catalent, Inc. Reaffirms Its Guidance Post Underwriters’ Exercise of Its Option to Purchase Additional Shares investment picks
The board of directors of Phillips 66 (NYSE: PSX), an energy manufacturing and logistics company, has approved an increase in 2014 capital spending to support the company’s growth strategy and authorized returning additional capital to shareholders.
Sign-up for Phillips 66 Board Approves Increased 2014 Capital Program and Additional Share Repurchases investment picks
Insmed Incorporated (Nasdaq:INSM) announced the closing of a $115.1 million underwritten public offering of 10,235,000 shares of common stock, including 1,335,000 shares of common stock which were issued pursuant to the exercise of the underwriters' option to purchase additional shares, at a price of $11.25 per share to the public.
Sign-up for Insmed Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares investment picks
SANTA MONICA, Calif., June 23, 2014 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq:KITE) , a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT™) products for the treatment of cancer, today announced that the underwriters of its previously announced initial public offering have exercised in full their option to purchase an additional 1,125,000 shares of Kite Pharma's common stock at the public offering price of $17.00 per share, less customary underwriting discounts and commissions.
Sign-up for Kite Pharma Announces Full Exercise of Underwriters' Option to Purchase Additional Shares investment picks
HealthEquity, Inc. (Nasdaq: HQY), one of the largest U.S. Health Savings Account non-bank custodians, today announced that the underwriters of its previously announced initial public offering of 9,100,000 shares of common stock exercised in full their over-allotment option to purchase an additional 1,365,000 shares of common stock from HealthEquity at the initial public offering price of $14.00 per share, less customary underwriting discounts and commissions.
Sign-up for HealthEquity Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares investment picks
Pebblebrook Hotel Trust (NYSE: PEB) (the “Company”) today announced that it has closed its previously announced public follow-on offering of 3,450,000 of its common shares, including 450,000 common shares issued pursuant to the full exercise of the underwriter’s option to purchase additional common shares, for net proceeds of approximately $131.4 million, after deducting estimated offering-related expenses.
Sign-up for Pebblebrook Hotel Trust Announces Exercise of Underwriter’s Option to Purchase Additional Shares and Subsequent Closing of Public Offering of Common Shares investment picks
NEWARK, Calif., June 24, 2014 (GLOBE NEWSWIRE) -- Revance Therapeutics, Inc. (Nasdaq:RVNC) , a biopharmaceutical company developing botulinum toxin products for use in aesthetic and therapeutic indications, announced today the closing of its follow-on public offering of 4,600,000 shares of common stock at a public offering price of $30.50 per share.
Sign-up for Revance Therapeutics Announces Closing of Its Follow-on Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares investment picks
NEW YORK , June 19, 2014 /PRNewswire/ -- Five Oaks Investment Corp.
Sign-up for Five Oaks Investment Corp. Announces Pricing of Additional Shares of Common Stock investment picks
LA JOLLA, Calif., July 16, 2014 (GLOBE NEWSWIRE) -- Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX) , a late clinical stage biopharmaceutical company focused on developing and commercializing novel medicines for the treatment of orphan diseases, announced today the completion of its underwritten public offering of 3,622,500 shares of its common stock at a public offering price of $19.25 per share.
Sign-up for Auspex Announces Completion of Follow on Offering and Exercise of Underwriters' Option to Purchase Additional Shares investment picks
http://media.marketwire.com/attachments/201311/201237_ExcelTrustForWeb.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1126852&ProfileId=051205&sourceType=1 SAN DIEGO, CA --
Sign-up for Excel Trust Completes $167.6 Million Offering of Common Stock, Including the Full Exercise of the Underwriters' Option to Purchase Additional Shares investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Additional Shares
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Additional Securities  |  Next: Additional Terms